A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects

NCT03372044 PHASE1 COMPLETED

An open-label study to understand the effect of different modified release and immediate release formulations on plasma PF-06865571 concentrations after single oral administration under fed conditions

Details

Lead sponsor	Pfizer
Phase	PHASE1
Status	COMPLETED
Enrolment	12
Start date	Fri Jan 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Apr 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Healthy

Interventions

• PF-06865571 Immediate release suspension
• PF-06865571 Slow release MR tablets
• PF-06865571 Fast release MR tablets
• PF-06865571 Immediate release tablets

Countries

Belgium